Global Blood Therapeutics (GBT) broke out to new highs last week and remains strong today. Let's check out the charts of this clinical-stage biopharmaceutical company.
More from Investing
Optimism about AAPL and news from the Fed, as well as algorithms, seems to have staved off market worries of a pandemic for now.
Valuations for many enterprise software firms remain rich. But like chip companies, their earnings reports generally haven't done much to spoil the fun.
United Airlines Holdings has had a rough few weeks, but the shares might be getting ready to turn around.
Sometimes a speculative trade can pay off big.